For questions about financial assistance,1-844-DUPIXENT, option 1 or
click to learn more
DUPIXENT is an add-on maintenance treatment in adults and children
6 years of age and older with uncontrolled moderate-to-severe
eosinophilic or oral steroid dependent asthma that improves lung
function so that you can breathe better in as little as 2 weeks.
DUPIXENT is a biologic, which is a type of asthma medicine that is processed in the body differently than inhalers, oral medications (pills) or steroids. It is taken by injection under the skin (subcutaneous injection) once every 2 or 4 weeks depending on age and weight.
Breathe better in as
little as 2 weeks
Targets two of the
key sources of
airway inflammation
Help prevent
asthma attacks
Can reduce or eliminate
oral steroid use in
adults and adolescents
aNew adult and pediatric patients (6+ years of age and older) with uncontrolled moderate-to-severe eosinophilic or oral corticosteroid dependent asthma.
bNBRx IQVIA data through June 2024.
Today, I do not think about when my next attack will
be, and that has allowed me to DU More of the
things I love, like playing with my grandchildren.
Marlena,
Real patient. Individual results may vary.
As little as $0* copay may be available
With the DUPIXENT MyWay Copay Card, eligible, commercially insured patients may pay as little as $0* copay per fill of DUPIXENT. If you’re eligible, you can sign up online and your card will be sent via email. View full copay card Terms & Restrictions.
CHECK COPAY CARD ELIGIBILITYUse this Healthgrades™ tool to easily find nearby specialists with experience in treating children, teens, and adults with uncontrolled moderate-to-severe eosinophilic or oral steroid dependent asthma.
Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.
Sign up to receive exclusive DUPIXENT emails and resources, providing information on how DUPIXENT works, its cost and coverage, accessing DUPIXENT, injection support, and more.